Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
480.7 USD | +0.35% | -0.48% | +18.15% |
01:57pm | Argus Adjusts Price Target on Vertex Pharmaceuticals to $550 From $465 | MT |
Jun. 14 | Vertex Pharmaceuticals Says Gene-Editing Therapy Demonstrates Clinical Benefits in Genetic Disease Trials | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.15% | 124B | |
+18.02% | 112B | |
+4.34% | 22.94B | |
-9.86% | 17.02B | |
-16.54% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B | |
+106.26% | 10.31B | |
+16.15% | 7.94B |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Vertex Pharmaceuticals : quaterly earnings release